Evotec SE(EVO)Earnings, Financials & Key Ratios
EVO•NASDAQ
$3.24
$1.15B mkt cap·Price updated May 6, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryContract development and manufacturing services
AboutEvotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.Show more
- Revenue$757M-5.0%
- EBITDA-$40M+2.8%
- Net Income-$99M+49.3%
- EPS (Diluted)-0.28+50.0%
- Gross Margin8.27%-42.6%
- EBITDA Margin-5.25%-2.3%
- Operating Margin-17.87%
- Net Margin-13.13%+46.6%
- ROE-11.26%+40.5%
- ROIC-10.5%-23.5%
- Debt/Equity0.55+18.2%
- Interest Coverage-9.75+37.4%
EVO Key Insights
Evotec SE (EVO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 1.2x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
EVO Price & Volume
Evotec SE (EVO) stock price & volume — 10-year historical chart
Loading chart...
EVO Growth Metrics
Evotec SE (EVO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years19.48%
5 Years8.62%
3 Years0.26%
TTM-1.38%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM47.14%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM47.42%
Return on Capital
10 Years3.25%
5 Years-3.34%
3 Years-6.71%
Last Year-9.09%
EVO Recent Earnings
Evotec SE (EVO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 1/12 qtrs (8%)●Beat Revenue 4/12 qtrs (40%)
Q2 2026Latest
Apr 8, 2026EPS
$0.06
Est $0.21
-73.9%
Revenue
$347M
Est $329M
+5.5%
Q4 2025
Nov 5, 2025EPS
$0.14
Est $0.14
-1.4%
Revenue
$192M
Est $240M
-20.0%
Q3 2025
Aug 13, 2025EPS
$0.14
Est $0.18
+19.9%
Revenue
$202M
Est $192M
+5.1%
Q2 2025
May 6, 2025EPS
$0.20
Est $0.11
-77.3%
Revenue
$219M
Est $276M
-20.5%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 8, 2026 | $0.06vs $0.21-73.9% | $347Mvs $329M+5.5% |
| Q4 2025 | Nov 5, 2025 | $0.14vs $0.14-1.4% | $192Mvs $240M-20.0% |
| Q3 2025 | Aug 13, 2025 | $0.14vs $0.18+19.9% | $202Mvs $192M+5.1% |
| Q2 2025 | May 6, 2025 | $0.20vs $0.11-77.3% | $219Mvs $276M-20.5% |
Based on last 12 quarters of dataView full earnings history →
EVO Peer Comparison
Evotec SE (EVO) competitors in Contract development and manufacturing services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 IQV | 29.95B | 176.47 | 22.51 | 5.87% | 8.33% | 22.11% | 2.44 | |
 CRL | 8.97B | 181.73 | -62.45 | -0.85% | -3.59% | -4.34% | 0.95 | |
 MEDP | 12.19B | 426.79 | 27.93 | 19.97% | 17.19% | 120.89% | 0.55 | |
 LSCC | 17.15B | 125.19 | 5613.90 | 2.72% | 3.46% | 2.79% | 0.11 | |
 RXRX | 1.53B | 3.43 | -2.38 | 26.92% | -8.44% | -54.32% | 0.07 | |
 SDGR | 969.87M | 12.98 | -9.21 | 23.29% | -40.6% | -30.85% | 0.30 | |
 ABCL | 1.52B | 5.04 | -10.29 | 160.56% | -194.89% | -15.14% | 0.14 | |
 TMO | 175.76B | 472.95 | 26.66 | 3.91% | 15.18% | 13.23% | 0.76 |
Compare EVO vs Peers
Evotec SE (EVO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
EVO Income Statement
Evotec SE (EVO) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 257.63M | 375.4M | 446.44M | 500.92M | 618.03M | 751.45M | 781.43M | 796.97M | 757.26M |
| Revenue Growth % | 56.61% | 45.71% | 18.92% | 12.2% | 23.38% | 21.59% | 3.99% | 1.99% | -4.98% |
| Cost of Goods Sold | 175.06M | 263.39M | 313.55M | 375.18M | 466.49M | 577.38M | 606.38M | 682.09M | 694.6M |
| COGS % of Revenue | 67.95% | 70.16% | 70.23% | 74.9% | 75.48% | 76.84% | 77.6% | 85.59% | 91.73% |
| Gross Profit | 82.57M▲ 0% | 112.02M▲ 35.7% | 132.89M▲ 18.6% | 125.74M▼ 5.4% | 151.54M▲ 20.5% | 174.06M▲ 14.9% | 175.05M▲ 0.6% | 114.88M▼ 34.4% | 62.66M▼ 45.5% |
| Gross Margin % | 32.05% | 29.84% | 29.77% | 25.1% | 24.52% | 23.16% | 22.4% | 14.41% | 8.27% |
| Gross Profit Growth % | 41.01% | 35.67% | 18.64% | -5.38% | 20.52% | 14.86% | 0.57% | -34.37% | -45.45% |
| Operating Expenses | 43.89M | 49.22M | 58.38M | 77.19M | 110.55M | 153.22M | 222.56M | 257.4M | 197.97M |
| OpEx % of Revenue | 17.04% | 13.11% | 13.08% | 15.41% | 17.89% | 20.39% | 28.48% | 32.3% | 26.14% |
| Selling, General & Admin | 42.38M | 57.01M | 66.43M | 77.2M | 105.44M | 156.19M | 169.61M | 188.2M | 123.65M |
| SG&A % of Revenue | 16.45% | 15.19% | 14.88% | 15.41% | 17.06% | 20.79% | 21.71% | 23.61% | 16.33% |
| Research & Development | 17.61M | 35.62M | 58.43M | 59.61M | 65.7M | 76.64M | 68.53M | 50.86M | 74.33M |
| R&D % of Revenue | 6.84% | 9.49% | 13.09% | 11.9% | 10.63% | 10.2% | 8.77% | 6.38% | 9.82% |
| Other Operating Expenses | -209K | 257K | -66.6M | -59.63M | -60.6M | -79.62M | -15.58M | 18.34M | 0 |
| Operating Income | 37.49M▲ 0% | 77.46M▲ 106.6% | 62.59M▼ 19.2% | 48.56M▼ 22.4% | 41M▼ 15.6% | 20.85M▼ 49.1% | -47.51M▼ 327.9% | -142.52M▼ 200.0% | -135.31M▲ 5.1% |
| Operating Margin % | 14.55% | 20.63% | 14.02% | 9.69% | 6.63% | 2.77% | -6.08% | -17.88% | -17.87% |
| Operating Income Growth % | 19.63% | 106.6% | -19.2% | -22.43% | -15.57% | -49.14% | -327.85% | -200% | 5.06% |
| EBITDA | 58.26M | 108.76M | 111.4M | 104.61M | 111.39M | 104.05M | 45.47M | -40.9M | -39.76M |
| EBITDA Margin % | 22.61% | 28.97% | 24.95% | 20.88% | 18.02% | 13.85% | 5.82% | -5.13% | -5.25% |
| EBITDA Growth % | 34.75% | 86.67% | 2.43% | -6.09% | 6.48% | -6.6% | -56.3% | -189.95% | 2.79% |
| D&A (Non-Cash Add-back) | 20.77M | 31.29M | 48.81M | 56.06M | 70.4M | 83.2M | 92.98M | 101.62M | 95.55M |
| EBIT | 26.83M | 74.59M | 37.96M | 34.3M | 246.23M | -140.81M | -68.85M | -182.28M | -135.31M |
| Net Interest Income | -358K | -1.69M | -5.22M | -7.13M | -6.98M | -4.81M | -2.48M | -9.26M | -9.62M |
| Interest Income | 903K | 898K | 2.23M | 1.34M | 2.27M | 8.34M | 9.26M | 2.44M | 4.25M |
| Interest Expense | 1.26M | 2.59M | 7.46M | 8.46M | 9.25M | 13.15M | 11.74M | 11.7M | 13.87M |
| Other Income/Expense | -11.16M | -5.46M | -6.03M | -22.72M | 195.98M | -174.81M | -33.09M | -51.45M | 12M |
| Pretax Income | 26.33M▲ 0% | 72M▲ 173.4% | 56.56M▼ 21.4% | 25.84M▼ 54.3% | 236.98M▲ 817.1% | -153.96M▼ 165.0% | -80.59M▲ 47.7% | -193.98M▼ 140.7% | -123.31M▲ 36.4% |
| Pretax Margin % | 10.22% | 19.18% | 12.67% | 5.16% | 38.34% | -20.49% | -10.31% | -24.34% | -16.28% |
| Income Tax | 2.33M | -12.06M | 19.33M | 19.56M | 21.47M | 21.7M | 3.32M | 2.1M | -23.88M |
| Effective Tax Rate % | 8.86% | -16.75% | 34.18% | 75.7% | 9.06% | -14.09% | -4.12% | -1.08% | 19.37% |
| Net Income | 24.26M▲ 0% | 84.17M▲ 247.0% | 38.16M▼ 54.7% | 6.28M▼ 83.5% | 215.51M▲ 3332.8% | -175.66M▼ 181.5% | -83.91M▲ 52.2% | -196.08M▼ 133.7% | -99.43M▲ 49.3% |
| Net Margin % | 9.42% | 22.42% | 8.55% | 1.25% | 34.87% | -23.38% | -10.74% | -24.6% | -13.13% |
| Net Income Growth % | -11.89% | 247% | -54.67% | -83.55% | 3332.78% | -181.51% | 52.23% | -133.67% | 49.29% |
| Net Income (Continuing) | 25M | 84.06M | 37.31M | 6.28M | 215.51M | -175.66M | -83.91M | -196.08M | -99.43M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 992K | 876K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.08▲ 0% | 0.28▲ 250.0% | 0.13▼ 53.6% | 0.02▼ 84.6% | 0.65▲ 3150.0% | -0.49▼ 175.4% | -0.23▲ 53.1% | -0.56▼ 143.5% | -0.28▲ 50.0% |
| EPS Growth % | -20% | 250% | -53.57% | -84.62% | 3150% | -175.38% | 53.06% | -143.48% | 50% |
| EPS (Basic) | 0.08 | 0.28 | 0.13 | 0.02 | 0.65 | -0.49 | -0.23 | -0.56 | -0.28 |
| Diluted Shares Outstanding | 290.02M | 294.96M | 299.45M | 307.5M | 332.81M | 353.41M | 353.87M | 354.59M | 355.16M |
| Basic Shares Outstanding | 290.02M | 294.96M | 299.45M | 307.5M | 332.81M | 353.35M | 353.87M | 353.29M | 355.16M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
EVO Balance Sheet
Evotec SE (EVO) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 180.25M | 249.77M | 527.05M | 806.13M | 1.1B | 1.07B | 903.16M | 681.96M | 762.62M |
| Cash & Short-Term Investments | 101.58M | 149.88M | 359.22M | 589.67M | 858.5M | 707.31M | 604.11M | 396.8M | 476.19M |
| Cash Only | 67.02M | 109.06M | 310.97M | 517.05M | 699.33M | 400.7M | 510.91M | 306.39M | 418.34M |
| Short-Term Investments | 34.56M | 40.82M | 48.25M | 72.62M | 159.17M | 306.61M | 93.2M | 90.41M | 57.85M |
| Accounts Receivable | 69.98M | 60.94M | 139.34M | 167.48M | 176.75M | 275.77M | 221.9M | 218.38M | 213.42M |
| Days Sales Outstanding | 99.14 | 59.25 | 113.92 | 122.03 | 104.39 | 133.95 | 103.65 | 100.02 | 102.87 |
| Inventory | 9.02M | 5.66M | 12.07M | 16.62M | 25.79M | 29.82M | 30.89M | 31.12M | 29.3M |
| Days Inventory Outstanding | 18.8 | 7.84 | 14.05 | 16.17 | 20.18 | 18.85 | 18.59 | 16.65 | 15.4 |
| Other Current Assets | 17.03M | 25.27M | 6.13M | 21.04M | 20.68M | 43.82M | 27.87M | 13.42M | 24.75M |
| Total Non-Current Assets | 487.02M | 522.11M | 852.81M | 1.03B | 1.13B | 1.18B | 1.35B | 1.23B | 1.02B |
| Property, Plant & Equipment | 74.66M | 90.52M | 268.53M | 412.7M | 484.6M | 650.2M | 806.56M | 823.94M | 554.39M |
| Fixed Asset Turnover | 3.45x | 4.15x | 1.66x | 1.21x | 1.28x | 1.16x | 0.97x | 0.97x | 1.37x |
| Goodwill | 220.18M | 220.79M | 287.27M | 302.67M | 257.57M | 274.82M | 275.63M | 282.85M | 272.25M |
| Intangible Assets | 135.03M | 122.99M | 131.33M | 119.95M | 30.85M | 23.82M | 15.45M | 26.44M | 31.56M |
| Long-Term Investments | 22.14M | 28.99M | 46.31M | 72.22M | 287.01M | 150.33M | 142.09M | 42.15M | 52.61M |
| Other Non-Current Assets | 15.77M | 15.5M | 26.56M | 45.73M | 56.84M | 74.08M | 95.23M | 37.82M | 36.84M |
| Total Assets | 667.27M▲ 0% | 771.88M▲ 15.7% | 1.38B▲ 78.8% | 1.84B▲ 33.2% | 2.24B▲ 21.6% | 2.26B▲ 1.0% | 2.25B▼ 0.2% | 1.91B▼ 15.1% | 1.78B▼ 7.0% |
| Asset Turnover | 0.39x | 0.49x | 0.32x | 0.27x | 0.28x | 0.33x | 0.35x | 0.42x | 0.43x |
| Asset Growth % | 89.91% | 15.68% | 78.76% | 33.18% | 21.63% | 0.99% | -0.21% | -15.09% | -7.03% |
| Total Current Liabilities | 245.78M | 196.28M | 200.88M | 255.06M | 324.52M | 337.71M | 464.57M | 344.58M | 367.92M |
| Accounts Payable | 26.08M | 31.14M | 35.16M | 52.06M | 72.6M | 97.28M | 134.32M | 85.79M | 64.74M |
| Days Payables Outstanding | 54.37 | 43.15 | 40.92 | 50.65 | 56.8 | 61.49 | 80.85 | 45.91 | 34.02 |
| Short-Term Debt | 167.76M | 55.07M | 23.27M | 36.72M | 36.14M | 1.56M | 149.1M | 50.8M | 103.64M |
| Deferred Revenue (Current) | 18.99M | 61.19M | 82.4M | 86.44M | 126.78M | 136.67M | 107.86M | 109.81M | 108.02M |
| Other Current Liabilities | 29.44M | 16.74M | 17.17M | 31.68M | 63.93M | 76.54M | 45.83M | 84.21M | 41.18M |
| Current Ratio | 0.73x | 1.27x | 2.62x | 3.16x | 3.39x | 3.18x | 1.94x | 1.98x | 2.07x |
| Quick Ratio | 0.70x | 1.24x | 2.56x | 3.10x | 3.31x | 3.09x | 1.88x | 1.89x | 1.99x |
| Cash Conversion Cycle | 63.57 | 23.95 | 87.04 | 87.56 | 67.77 | 91.31 | 41.39 | 70.76 | 84.25 |
| Total Non-Current Liabilities | 89.75M | 150.73M | 643.51M | 696.2M | 532.96M | 732.36M | 667.99M | 615.39M | 596.72M |
| Long-Term Debt | 20.3M | 54.68M | 364.68M | 405.02M | 326.34M | 328.3M | 477.11M | 392.74M | 194.82M |
| Capital Lease Obligations | 1.17M | 2.87M | 131.87M | 160.21M | 135.96M | 162M | 170.03M | 0 | 149.04M |
| Deferred Tax Liabilities | 23.5M | 21.52M | 78.08M | 73.39M | 17.69M | 18.52M | 18.14M | 14.52M | 79.51M |
| Other Non-Current Liabilities | 16.11M | 20.62M | 25.3M | 25.62M | 18.49M | 17.4M | -152.57M | 20.9M | 19.74M |
| Total Liabilities | 335.52M | 347M | 844.39M | 951.26M | 857.48M | 1.07B | 1.13B | 959.98M | 964.64M |
| Total Debt | 189.93M | 114.47M | 519.83M | 601.94M | 512.92M | 506.67M | 815.35M | 443.54M | 447.5M |
| Net Debt | 122.91M | 5.41M | 208.86M | 84.9M | -186.41M | 105.98M | 304.44M | 137.15M | 29.16M |
| Debt / Equity | 0.57x | 0.27x | 0.97x | 0.68x | 0.37x | 0.43x | 0.73x | 0.47x | 0.55x |
| Debt / EBITDA | 3.26x | 1.05x | 4.67x | 5.75x | 4.60x | 4.87x | 17.93x | - | - |
| Net Debt / EBITDA | 2.11x | 0.05x | 1.87x | 0.81x | -1.67x | 1.02x | 6.70x | - | - |
| Interest Coverage | 21.27x | 28.79x | 5.09x | 4.05x | 26.61x | -10.71x | -5.87x | -15.58x | -9.75x |
| Total Equity | 331.75M▲ 0% | 424.88M▲ 28.1% | 535.47M▲ 26.0% | 886.41M▲ 65.5% | 1.38B▲ 55.4% | 1.19B▼ 13.8% | 1.12B▼ 5.7% | 952.52M▼ 14.9% | 813.36M▼ 14.6% |
| Equity Growth % | 55.07% | 28.07% | 26.03% | 65.54% | 55.42% | -13.83% | -5.67% | -14.95% | -14.61% |
| Book Value per Share | 1.14 | 1.44 | 1.79 | 2.88 | 4.14 | 3.36 | 3.16 | 2.69 | 2.29 |
| Total Shareholders' Equity | 330.75M | 424M | 535.47M | 886.41M | 1.38B | 1.19B | 1.12B | 952.52M | 813.36M |
| Common Stock | 147.53M | 149.06M | 169.39M | 200.56M | 176.61M | 176.95M | 177.19M | 177.55M | 177.7M |
| Retained Earnings | -566.73M | -481.01M | -495.22M | -529.36M | -216.42M | -392.38M | -476.29M | -672.37M | -775.56M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.55M |
| Accumulated OCI | -28.9M | -27.2M | -21.96M | -45.91M | -12.64M | -37.4M | -30.64M | -7.35M | -45.09M |
| Minority Interest | 992K | 876K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EVO Cash Flow Statement
Evotec SE (EVO) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 10.83M | 156.24M | 42.22M | 44.72M | 122.24M | 205.81M | 36.44M | 18.22M | -9.06M |
| Operating CF Margin % | 4.2% | 41.62% | 9.46% | 8.93% | 19.78% | 27.39% | 4.66% | 2.29% | -1.2% |
| Operating CF Growth % | -83.93% | 1342.93% | -72.98% | 5.93% | 173.33% | 68.37% | -82.29% | -50% | -149.75% |
| Net Income | 24M | 84.06M | 37.31M | 6.25M | 215.51M | -175.66M | -83.91M | -196.08M | -99.43M |
| Depreciation & Amortization | 20.77M | 31.29M | 48.8M | 56.06M | 67.61M | 83.2M | 92.98M | 101.62M | 95.55M |
| Stock-Based Compensation | 2.92M | 4.25M | 3.65M | 5.29M | 7.8M | 9.92M | 9.63M | 5.04M | 0 |
| Deferred Taxes | -6.14M | -26.12M | 6.74M | 7.49M | 5.07M | 21.7M | 3.32M | 2.1M | 14.11M |
| Other Non-Cash Items | 4.97M | -9.17M | 14.61M | 6.51M | -171.47M | 161.37M | 24.37M | 173.75M | 39.11M |
| Working Capital Changes | -35.68M | 71.93M | -68.9M | -36.87M | -2.28M | 105.28M | -9.94M | -68.21M | -58.4M |
| Change in Receivables | -7.88M | -1.85M | -49.33M | -4.18M | -48.03M | -53.68M | 0 | 0 | -27.6M |
| Change in Inventory | 814K | -283K | -1.36M | -3.63M | -11.65M | -4.41M | 0 | 0 | -9.18M |
| Change in Payables | 1.9M | 5.01M | -2.03M | 2.17M | 31.34M | 24.55M | 0 | 0 | -7.02M |
| Cash from Investing | -269.03M | -39.13M | -86.63M | -155.09M | -243.85M | -412.8M | -13.29M | -71.19M | 159.86M |
| Capital Expenditures | -17.59M | -27.87M | -31.32M | -99.07M | -118.94M | -181.35M | -213.32M | -117.47M | -79.36M |
| CapEx % of Revenue | 6.83% | 7.42% | 7.02% | 19.78% | 19.25% | 24.13% | 27.3% | 14.74% | 10.48% |
| Acquisitions | -270.32M | 5.17M | -52.15M | -33.63M | -21.09M | -83.82M | -20.16M | 42.78M | 213.76M |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 691K | -2.14M | -583K | -6.24M | -7.38M | 3.03M | 8.22M | -2.78M | 0 |
| Cash from Financing | 240.72M | -77.76M | 211.26M | 246.41M | 398.43M | -58.15M | 71.96M | -161.42M | -30.93M |
| Debt Issued (Net) | 148.37M | -79.34M | 209.36M | -5.16M | 14.77M | -53.11M | 84.6M | -152.07M | -6.96M |
| Equity Issued (Net) | 90.25M | 0 | 0 | 249.97M | 404.32M | 355K | 0 | 0 | -1.27M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 2.11M | 1.58M | 1.9M | 1.59M | -20.66M | -5.39M | -12.63M | -9.35M | -22.71M |
| Net Change in Cash | -16.92M▲ 0% | 42.04M▲ 348.4% | 167.98M▲ 299.6% | 145.55M▼ 13.4% | 276.75M▲ 90.1% | -284.17M▼ 202.7% | 95.75M▲ 133.7% | -204.52M▼ 313.6% | 148.32M▲ 172.5% |
| Free Cash Flow | -6.76M▲ 0% | 128.37M▲ 1999.3% | 10.31M▼ 92.0% | -54.35M▼ 627.1% | 3.29M▲ 106.1% | 24.46M▲ 642.5% | -179.56M▼ 834.2% | -114.02M▲ 36.5% | -78.74M▲ 30.9% |
| FCF Margin % | -2.62% | 34.2% | 2.31% | -10.85% | 0.53% | 3.25% | -22.98% | -14.31% | -10.4% |
| FCF Growth % | -111.81% | 1999.29% | -91.97% | -627.12% | 106.06% | 642.47% | -834.18% | 36.5% | 30.94% |
| FCF per Share | -0.02 | 0.44 | 0.03 | -0.18 | 0.01 | 0.07 | -0.51 | -0.32 | -0.22 |
| FCF Conversion (FCF/Net Income) | 0.45x | 1.86x | 1.11x | 7.12x | 0.57x | -1.17x | -0.43x | -0.09x | 0.09x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EVO Key Ratios
Evotec SE (EVO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 13.73% | 8.89% | 22.25% | 7.95% | 0.88% | 19.04% | -13.7% | -7.27% | -18.92% | -11.26% |
| Return on Invested Capital (ROIC) | 14.49% | 9.17% | 13.13% | 7.99% | 4.25% | 2.84% | 1.26% | -2.62% | -8.5% | -10.5% |
| Gross Margin | 35.59% | 32.05% | 29.84% | 29.77% | 25.1% | 24.52% | 23.16% | 22.4% | 14.41% | 8.27% |
| Net Margin | 16.73% | 9.42% | 22.42% | 8.55% | 1.25% | 34.87% | -23.38% | -10.74% | -24.6% | -13.13% |
| Debt / Equity | 0.13x | 0.57x | 0.27x | 0.97x | 0.68x | 0.37x | 0.43x | 0.73x | 0.47x | 0.55x |
| Interest Coverage | 22.63x | 21.27x | 28.79x | 5.09x | 4.05x | 26.61x | -10.71x | -5.87x | -15.58x | -9.75x |
| FCF Conversion | 2.45x | 0.45x | 1.86x | 1.11x | 7.12x | 0.57x | -1.17x | -0.43x | -0.09x | 0.09x |
| Revenue Growth | 28.85% | 56.61% | 45.71% | 18.92% | 12.2% | 23.38% | 21.59% | 3.99% | 1.99% | -4.98% |
EVO Frequently Asked Questions
Evotec SE (EVO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Evotec SE (EVO) reported $786.0M in revenue for fiscal year 2025. This represents a 21897% increase from $3.6M in 2003.
Evotec SE (EVO) saw revenue decline by 5.0% over the past year.
Evotec SE (EVO) reported a net loss of $103.7M for fiscal year 2025.
Dividend & Returns
Evotec SE (EVO) has a return on equity (ROE) of -11.3%. Negative ROE indicates the company is unprofitable.
Evotec SE (EVO) had negative free cash flow of $92.2M in fiscal year 2025, likely due to heavy capital investments.
Explore More EVO
Evotec SE (EVO) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates